Meclizine HCl Tablets — Class II drug recall D-0259-2021
Terminated recall by Wilshire Pharmaceuticals Inc, reported 2021-02-24, distributed in FL, TX. Failed Dissolution Specifications
| Recall number | D-0259-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Wilshire Pharmaceuticals Inc, Atlanta, GA, United States |
| Recall initiated | 2021-02-04 |
| Classified | 2021-02-16 |
| Reported by FDA | 2021-02-24 |
| Terminated | 2023-06-02 |
| Distributed | FL, TX |
| Quantity | 35,928 bottles |
| Reason classes | specification failure |
| NDC | 52536-0133-01 |
| Lot numbers | 18030329, 18030330, 18030331 |
| Expiration dates | 2021-03 |
Product
Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-133-01
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0259-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.